The pressure-overloaded right ventricle in pulmonary hypertension

Chest

Volumn 114, Issue 1 SUPPL., 1998, Pages 101S-106S

  Bristow, Michael R ^a   Zisman, Lawrence S ^a   Lowes, Brian D ^a   Abraham, William T ^a   Badesch, David B ^a   Groves, Bertron M ^a   Voelkel, Norbert F ^a   Lynch, David M B ^a   Quaife, Robert A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MYOSIN HEAVY CHAIN; PROSTACYCLIN; VASODILATOR AGENT; WARFARIN;

ADRENERGIC SYSTEM; CONFERENCE PAPER; GENE EXPRESSION; GENETIC VARIABILITY; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE PRESSURE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031857607     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1_Supplement.101S     Document Type: Conference Paper

References (27)

1. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thromshy; bosis. Circulation 1984; 70:580-87
2. D'Alonzo GE, Barst RJ, Ayers SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-49
3. Sandoval J, Bauerle O, Palomar A, et al. Survival in primary pulmonary hypertension: validation of a prognostic equation. Circulation 1994; 89:1733-44
4. Bristow MR, Ginsburg R, Minobe WA, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982; 307:205-11
5. Bristow MR, Minobe W, Rasmussen R, et al. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local, rather than systemic mechanisms. J Clin Invest 1992; 89:803-15
6. Lowes BD, Minobe WA, Abraham WT, et al. Changes in gene expression in the intact human heart: down-regulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997; 100:2315-24
7. Abraham WT, Raynolds MV, Gottschall B, et al. Importance of angiotensin-converting enzyme in pulmonary hypertenshy; sion. Cardiology 1995; 86(suppl 1):9-15
8. Konstam MA, Cohen SR, Salem DN, et al. Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. J Am Coll Cardiol 1985; 5:1326-34
9. Boxt LM, Katz FJ, Kolb T. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992; 19:1508-15
10. Werchan PM, Summer WR, Gerdes AM, et al. Right ventricshy; ular performance after monocrotaline-induced pulmonary hypertension. Am J Physiol 1989; 256:H1328-36
11. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conshy; ventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334:296-301
12. Califf RM, Adams KF, Armstrong PW, et al. Flolan Internashy; tional Randomized Survival Trial Study (FIRST): final results. J Am Coll Cardiol 1996; 27(suppl A):141A
13. Glanville AR, Burke CM, Theodore J, et al. Primary pulmoshy; nary hypertension: length of survival in patients referred for heart-lung transplantation. Chest 1987; 91:675-81
14. Eichhorn EJ, Bristow MR. Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation 1996; 94:2285-96
15. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angioshy; tensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197-205
16. J Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/ insertion polymorphism. Circulation 1995; 92:1387-88
17. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997; 80:26L-40L
18. 2-adrenergic receptor. Science 1994; 264:562-66
19. Zisman LS, Asano K, Dutcher DL, et al. Differential regulashy; tion of cardiac angiotensin converting enzyme (ACE) binding sites and AT1 receptor density in primary pulmonary hypershy; tension (PPH). J Am Coll Cardiol 1997; 29(suppl A):244A
20. Feldman AM, Ray PE, Silan CM, et al. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 1991; 83: 1866-72
21. Nakao K, Minobe WA, Roden RL, et al. Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997; 100:2362-70
22. Oakley C. Importance of right ventricular function in congesshy; tive heart failure. Am J Cardiol 1988; 62:14A-19A
23. Carere R, Patterson GA, Liu P, et al. Right and left ventricshy; ular performance after single and double lung transplantashy; tion. J Thorac Cardiovasc Surg 1991; 102:115-23
24. Globits S, Burghuber OC, Koller J, et al. Effect of lung transplantation on right and left ventricular volumes and function measured by magnetic resonance imaging. Am J Respir Crit Care Med 1994; 149:1000-04
25. Hinderliter AL, Willis PW, Barst RJ, et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardioshy; graphic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997; 95: 1479-86
26. Greenberg B, Quinones MA, Koilpillai C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD Echocardiography Substudy. Circulation 1995; 91: 2573-81
27. Grossman W, Jones D, McLaurin LP. Wall stress and patshy; terns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56:56-64